{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-081777","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2022-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.266657+00:00","generated_at":"2026-06-21T00:59:59.428991+00:00","sec_items":["3.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Health Sciences Acquisitions Corp 2 extends business combination deadline to February 6, 2023","bullets":["Company's directors elected to extend deadline to February 6, 2023, from prior extended date of November 6, 2022.","Extension approved by shareholders in July 2022; allows up to three monthly extensions without another vote.","If no business combination by Feb 6, 2023, company will cease operations, redeem shares, and liquidate."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-081777","json":"https://secwatch.observer/filing/0001213900-22-081777.json","markdown":"https://secwatch.observer/filing/0001213900-22-081777.md","text":"https://secwatch.observer/filing/0001213900-22-081777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000121390022081777/0001213900-22-081777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000121390022081777/ea170608-8k_healthsci2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T00:59:59.428991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}